Trusti Diagnostics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Trusti Diagnostics Inc. - overview
Established
2024
Location
Toronto, ON, Canada
Primary Industry
Medical Devices & Equipment
About
Trusti Diagnostics Inc. specializes in at-home STI testing solutions, providing users with discreet, rapid testing options that prioritize convenience and privacy. Trusti Diagnostics Inc. develops at-home STI testing kits designed to enhance sexual health care accessibility.
Founded in Toronto, Canada, the company has raised a total of USD 300,000 through its latest funding round in May 2025, backed by LOI Venture. The founder has a history in the healthcare sector, having been involved in other health-related ventures prior to Trusti. Trusti Diagnostics Inc. offers a range of at-home STI testing kits, primarily featuring the tru sti™ HIV Testing Kit, which employs the INSTI® HIV-1/2 Antibody Self Test.
This kit provides results in 60 seconds with over 99% accuracy, facilitating immediate insight into users' health without traditional clinical settings. The company's services aim to alleviate the discomfort associated with conventional STI testing, making sexual health care more accessible. Trusti’s market primarily includes North American individuals seeking immediate testing solutions, with plans to expand into additional markets. The company emphasizes privacy and easy access to medical support through its online platform and events for purchasing kits directly.
Trusti Diagnostics Inc. generates revenue through direct sales of its at-home testing kits, priced at USD 60 per kit. Customers can purchase products from the tru sti™ website or during company-hosted events. The direct-to-consumer sales model ensures immediate access to health testing without intermediaries.
The company focuses on efficient delivery to consumers, and future revenue potential may increase as it expands its product portfolio to include more at-home tests and considers subscription models for continuous health management. In May 2025, Trusti Diagnostics Inc. raised USD 300,000 in pre-seed funding from new investor LOI Venture, which will be utilized to support nationwide expansion into the U. S.
by 2026. The company plans to enhance its product line with new testing options that cater to evolving consumer needs, although specific product launches and timelines have not yet been disclosed. Targeting new geographical markets, Trusti aims to establish a presence in additional regions, further enhancing accessibility to its testing services.
Current Investors
LOI Venture
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Internet
Website
www.trusti.ca/
Verticals
E-commerce, Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.